Chester County News and Community Website
PHILADELPHIA, PA — Tolerance Bio Inc. has secured global development rights to an experimental immune therapy from Japan’s Tanabe Pharma Corporation in a licensing agreement carrying potential milestone payments of …
Tolerance Bio Secures Drug Rights in $560 Million Deal Read More PHILADELPHIA, PA — Tolerance Bio Inc. licensed regional rights to NeoImmuneTech’s clinical-stage immune therapy efineptakin alfa in a deal carrying as much as $260 million in potential milestone payments, moving …
Tolerance Bio Licenses IL-7 Drug in Deal Worth Up to $260 Million Read More PHILADELPHIA, PA — Tolerance Bio announced the publication of new research showing that lab-grown human thymic organoids can restore immune function and suppress tumor growth in melanoma, marking a potential …
Tolerance Bio Study Demonstrates Breakthrough in Regenerating Immune Function to Fight Cancer Read More